These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 34077499

  • 1. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
    Martens T, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, Davis G, Kruger D, Bhargava A, Young L, McGill JB, Aleppo G, Nguyen QT, Orozco I, Biggs W, Lucas KJ, Polonsky WH, Buse JB, Price D, Bergenstal RM, MOBILE Study Group.
    JAMA; 2021 Jun 08; 325(22):2262-2272. PubMed ID: 34077499
    [Abstract] [Full Text] [Related]

  • 2. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D, DIAMOND Study Group.
    JAMA; 2017 Jan 24; 317(4):371-378. PubMed ID: 28118453
    [Abstract] [Full Text] [Related]

  • 3. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM, Kanapka LG, Beck RW, Bergamo K, Clements MA, Criego A, DeSalvo DJ, Goland R, Hood K, Liljenquist D, Messer LH, Monzavi R, Mouse TJ, Prahalad P, Sherr J, Simmons JH, Wadwa RP, Weinstock RS, Willi SM, Miller KM, CGM Intervention in Teens and Young Adults with T1D (CITY) Study Group, CDE10.
    JAMA; 2020 Jun 16; 323(23):2388-2396. PubMed ID: 32543683
    [Abstract] [Full Text] [Related]

  • 4. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE, Kanapka LG, Rickels MR, Ahmann A, Aleppo G, Beck R, Bhargava A, Bode BW, Carlson A, Chaytor NS, Fox DS, Goland R, Hirsch IB, Kruger D, Kudva YC, Levy C, McGill JB, Peters A, Philipson L, Philis-Tsimikas A, Pop-Busui R, Shah VN, Thompson M, Vendrame F, Verdejo A, Weinstock RS, Young L, Miller KM, Wireless Innovation for Seniors With Diabetes Mellitus (WISDM) Study Group.
    JAMA; 2020 Jun 16; 323(23):2397-2406. PubMed ID: 32543682
    [Abstract] [Full Text] [Related]

  • 5. Magnitude of Glycemic Improvement in Patients with Type 2 Diabetes Treated with Basal Insulin: Subgroup Analyses from the MOBILE Study.
    Davis G, Bailey R, Calhoun P, Price D, Beck RW.
    Diabetes Technol Ther; 2022 May 16; 24(5):324-331. PubMed ID: 34962151
    [Abstract] [Full Text] [Related]

  • 6. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ, Parker MM, Moffet HH, Gilliam LK, Dlott R.
    JAMA; 2021 Jun 08; 325(22):2273-2284. PubMed ID: 34077502
    [Abstract] [Full Text] [Related]

  • 7. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D, Onishi Y, Norwood P, Huh R, Bray R, Patel H, Rodríguez Á.
    JAMA; 2022 Feb 08; 327(6):534-545. PubMed ID: 35133415
    [Abstract] [Full Text] [Related]

  • 8. Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.
    Rosenstock J, Frías JP, Rodbard HW, Tofé S, Sears E, Huh R, Fernández Landó L, Patel H.
    JAMA; 2023 Nov 07; 330(17):1631-1640. PubMed ID: 37786396
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin.
    Bao S, Bailey R, Calhoun P, Beck RW.
    Diabetes Technol Ther; 2022 May 07; 24(5):299-306. PubMed ID: 34939824
    [Abstract] [Full Text] [Related]

  • 10. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
    Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, McGill JB, Polonsky W, Price D, Aronoff S, Aronson R, Toschi E, Kollman C, Bergenstal R, DIAMOND Study Group.
    Ann Intern Med; 2017 Sep 19; 167(6):365-374. PubMed ID: 28828487
    [Abstract] [Full Text] [Related]

  • 11. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.
    Clin Ther; 2007 Nov 19; 29(11):2349-64. PubMed ID: 18158076
    [Abstract] [Full Text] [Related]

  • 12. Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes: The ONWARDS 3 Randomized Clinical Trial.
    Lingvay I, Asong M, Desouza C, Gourdy P, Kar S, Vianna A, Vilsbøll T, Vinther S, Mu Y.
    JAMA; 2023 Jul 18; 330(3):228-237. PubMed ID: 37354562
    [Abstract] [Full Text] [Related]

  • 13. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Ólafsdóttir AF, Frid A, Wedel H, Ahlén E, Nyström T, Hellman J.
    JAMA; 2017 Jan 24; 317(4):379-387. PubMed ID: 28118454
    [Abstract] [Full Text] [Related]

  • 14. With or Without Residual C-Peptide, Patients with Type 2 Diabetes Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring.
    Bailey R, Calhoun P, Chao C, Walker TC.
    Diabetes Technol Ther; 2022 Apr 24; 24(4):281-284. PubMed ID: 34704817
    [Abstract] [Full Text] [Related]

  • 15. Ultra rapid lispro improves postprandial glucose control versus lispro in combination with basal insulin: a study based on CGM in type 2 diabetes in China.
    Yuan L, Luo Y, Luo Y, Ding B, Zhang P, Ma J, Wu J.
    Front Endocrinol (Lausanne); 2024 Apr 24; 15():1364585. PubMed ID: 38774225
    [Abstract] [Full Text] [Related]

  • 16. Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial.
    Lind N, Christensen MB, Hansen DL, Nørgaard K.
    Diabetes Care; 2024 May 01; 47(5):881-889. PubMed ID: 38489032
    [Abstract] [Full Text] [Related]

  • 17. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
    Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C, DIAMOND Study Group.
    J Diabetes Sci Technol; 2017 Nov 01; 11(6):1138-1146. PubMed ID: 28449590
    [Abstract] [Full Text] [Related]

  • 18. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin.
    Aleppo G, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, Davis G, Kruger D, Bhargava A, Young L, Buse JB, McGill JB, Martens T, Nguyen QT, Orozco I, Biggs W, Lucas KJ, Polonsky WH, Price D, Bergenstal RM, MOBILE Study Group, Type 2 Diabetes Basal Insulin Users: The Mobile Study (MOBILE) Study Group:.
    Diabetes Care; 2021 Dec 01; 44(12):2729-2737. PubMed ID: 34588210
    [Abstract] [Full Text] [Related]

  • 19. Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
    Abraham MB, de Bock M, Smith GJ, Dart J, Fairchild JM, King BR, Ambler GR, Cameron FJ, McAuley SA, Keech AC, Jenkins A, Davis EA, O'Neal DN, Jones TW, Australian Juvenile Diabetes Research Fund Closed-Loop Research group.
    JAMA Pediatr; 2021 Dec 01; 175(12):1227-1235. PubMed ID: 34633418
    [Abstract] [Full Text] [Related]

  • 20. Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring.
    van den Heuvel T, Kolassa R, Keuthage W, Kroeger J, Ré R, de Portu S, Vorrink L, Shin J, Castañeda J, Vigersky R, Cohen O.
    J Diabetes Sci Technol; 2024 Sep 01; 18(5):1132-1138. PubMed ID: 36949671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.